Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/31417
Title: Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma
Authors: Andrade, Valeria C. C.
Vettore, Andre L. [UNIFESP]
Regis Silva, Maria Regina [UNIFESP]
Felix, Roberta S.
Almeida, Manuella S. S.
Carvalho, Fabricio de
Zago, Marco Antonio
Caballero, Otavia L.
Simpson, Andrew J.
Colleoni, Gisele W. B. [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Ludwig Inst Canc Res
Issue Date: 1-Apr-2009
Publisher: Elsevier B.V.
Citation: Experimental Hematology. New York: Elsevier B.V., v. 37, n. 4, p. 446-449, 2009.
Abstract: Objective. This study aims to analyze the expression of cancer testis antigen 45 (CT45) in normal tissues and in plasma cell disorders and to identify possible associations with clinical data and prognosis in multiple myeloma (MM) patients.Materials and Methods. Expression of CT45 was studied in 20 normal tissues (testis, placenta, skeletal muscle, bladder, lung, spleen, heart, brain and fetal brain, thymus, uterus, stomach, mammary gland, pancreas, prostate, small intestine, kidney, adrenal gland, spinal cord, colon, and one pool of 10 normal bone marrow samples) and bone marrow aspirates from 3 monoclonal gammopathies of undetermined significance, 5 solitary plasmacytomas, 61 newly diagnosed MM patients and MM cell line U266 by reverse transcriptase polymerase chain reaction.Results. CT45 was positive in 3 of 20 (15%) normal tissues tested: lung, brain (both fetal and adult), and spinal cord. Among monoclonal gammopathies, CT45 was positive in 2 of 5 (40%) solitary plasmacytomas bone marrow aspirates, 10 of 61 (16%) MM bone marrow aspirates, and in the U266 MM cell line.Conclusions. We did not find associations between bone marrow histology and CT45 expression. However, we demonstrated for the first time that positive expression of CT45 was associated with poor prognostic (international Staging System) and poor outcomes in MM patients, meaning that CT45-positive cases presented seven times more chance of worse evolution than the negative ones. (C) 2009 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc.
URI: http://repositorio.unifesp.br/handle/11600/31417
ISSN: 0301-472X
Other Identifiers: http://dx.doi.org/10.1016/j.exphem.2008.12.003
Appears in Collections:Artigo
Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.